Basel Breast Consortium Tricycle Seminar

Jorge Gomez, DBM, University Hospital Basel / Anton Oseledchyk, University Hospital, Basel / Roohi Ismail-Khan, Eli Lilly, Switzerland

"Identification of mechanisms of resistance to Fulvestrant plus Ribociclib in ER+/HER2-advanced breast cancer“

"Immunecheckpoint Blockade in Breast Cancer – Current and Future standard of Care"

"Imlunestrant, an oral selective estrogen receptor degrader, in estrogen receptor-positive advanced breast cancer"

Export event as iCal